阿斯特拉加索酸IV通过雌激素受体αα抑制了血管化
Michiko Nanao-Hamai1, Bo-Kyung Son2,3, Sumito Ogawa1
1Department of Geriatric Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Geriatrics & gerontology international
|December 5, 2024
概括
阿斯特拉加索酸IV通过通过雌激素受体α抑制血管化,为心血管提供益处. 然而,其类似雌激素的效应可能会增加乳腺癌细胞的增殖,需要进一步研究以确保安全应用.
科学领域:
- 药理学 药理学是指药理学的学科.
- 心血管科学 心血管科学
- 在瘤学瘤学.
背景情况:
- 甲酸IV (As-IV),是传统的日本Hozai的一个组成部分,具有类似于雌激素的类固醇结构.
- As-IV通过与雌激素受体α的相互作用来抑制血管化,证明了潜在的心血管益处.
相关概念视频
01:18Antihypertensive Drugs: Action of Calcium Channel Blockers
458
Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
458
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
455
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
455